Clinical Trials for Hepatocellular Carcinoma

Clinical Trial of TB511 in Advanced Solid Tumors

NCT ID: NCT06400160

This clinical trial is studying a new treatment called TB511 for patients with advanced solid tumors, such as non-small cell lung cancer (NSCLC), prostate cancer, colorectal cancer, and hepatocellu...

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

NCT ID: NCT06795022

This clinical trial is studying a new treatment called AZD9793 for patients with advanced or metastatic solid tumors, specifically focusing on those with a type of liver cancer known as hepatocellu...

Active Choice Clinical Decision Support (CDS): Hepatocellular Carcinoma (HCC) Screening in Patients With Cirrhosis

NCT ID: NCT06624189

CVM-1118 in Combination With Nivolumab for Unresectable Advanced Hepatocellular Carcinoma

NCT ID: NCT05257590

This clinical trial is studying a new treatment called CVM-1118 in combination with an existing cancer medication known as nivolumab for patients with advanced liver cancer (hepatocellular carcinom...

Efficacy and Safety of Liver Transplantation for Hepatocellular Carcinoma With Bile Duct Tumor Thrombus: a Single-arm, Multicenter, Prospective Study (HCC-BDTT in LT)

NCT ID: NCT06928415

This clinical trial is studying the effectiveness and safety of liver transplantation (LT) for patients with a specific type of liver cancer called hepatocellular carcinoma (HCC) that has spread in...

Liver and Biliary Tumor Tissue Registry

NCT ID: NCT02917759

The Liver and Biliary Tumor Tissue Registry is a clinical trial aimed at helping researchers learn more about liver and biliary diseases, specifically two types of cancer: hepatocellular carcinoma ...

IDOV-Immune for Advanced Solid Tumors

NCT ID: NCT06910657

This clinical trial is studying a new treatment called IDOV-Immune for adults with advanced solid tumors, such as colorectal, pancreatic, and breast cancers, that have not improved with standard th...

Identification of Innovative Biomarkers to Predict Outcomes in Hepatocellular Carcinoma Treated With Tremelimumab and Durvalumab

NCT ID: NCT06796114

This clinical trial is studying how well a combination of two immunotherapy drugs, tremelimumab and durvalumab, can help patients with hepatocellular carcinoma (HCC), a type of liver cancer. The tr...

An Exosome-Based Liquid Biopsy for the Differential Diagnosis of Primary Liver Cancer

NCT ID: NCT06342414

This clinical trial is focused on developing a new blood test, called a liquid biopsy, that can help doctors determine the specific type of primary liver cancer a patient has. Sometimes, it can be ...

Single Centre Prospective Evaluation of 68Gallium-FAPI PET/MRI in Hepatocellular Carcinoma

NCT ID: NCT05687747

This clinical trial is studying a new imaging technique called 68Gallium-FAPI PET/MRI to see how well it can help detect, characterize, and stage liver cancer, specifically hepatocellular carcinoma...

TACE Combined Surgery for the Resectable Huge HCC

NCT ID: NCT06898398

This clinical trial is studying a treatment approach for patients with large liver tumors known as hepatocellular carcinoma (HCC), specifically those tumors that are bigger than 10 centimeters. The...

Improving Hepatocellular Carcinoma Screening

NCT ID: NCT05828446

This clinical trial is focused on improving the way we detect hepatocellular carcinoma (HCC), a type of liver cancer. Researchers want to find out if using a special type of magnetic resonance imag...

TARGETed Therapy Drug MONITOring in DIGestive Oncology

NCT ID: NCT05443087

The TARGETed Therapy Drug MONITOring in DIGestive Oncology trial is researching how to better manage and adjust doses of specific cancer medications for patients with advanced digestive cancers, su...

Tumor Antigen Discovery for Innovative Cancer Immunotherapies in HCC: from Benchside to Bedside (HepAnt)

NCT ID: NCT06905262

The HepAnt trial is a study focused on finding new treatments for a type of liver cancer called hepatocellular carcinoma (HCC). Researchers are looking for specific molecules, known as tumor antige...

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

NCT ID: NCT05440708

This clinical trial is studying a new medication called TTI-101 to see how safe it is and how well it works for patients with a type of liver cancer known as hepatocellular carcinoma (HCC), which i...

Durvalumab and Tremelimumab With or Without Hepatic Arterial Infusion of Chemotherapy in Hepatocellular Carcinoma

NCT ID: NCT06904170

The ALICE clinical trial is studying a new treatment approach for patients with advanced liver cancer, specifically a type called hepatocellular carcinoma (HCC). This trial will evaluate the effect...

Biomarkers and Molecular Mechanism Study of Hepatocellular Carcinoma After Radical Resection and Conversion Therapy

NCT ID: NCT06382103

This clinical trial is studying how certain blood markers can help predict the long-term outcomes for patients with liver cancer, specifically hepatocellular carcinoma (HCC), after they have surger...

Immune Checkpoint Therapy vs Target Therapy in Reducing Serum HBsAg Levels in Patients With HBsAg+ Advanced Stage HCC

NCT ID: NCT03899428

This clinical trial is looking at two types of treatments—immune checkpoint therapy and targeted therapy—to see which one is better at lowering certain levels (called HBsAg) in patients with advanc...

The Overall Survival of Patients With Unresectable HCC in Real-life

NCT ID: NCT03612726

This clinical trial is studying how long patients can live after being diagnosed with unresectable hepatocellular carcinoma (HCC), which is a type of liver cancer that cannot be surgically removed....

Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors

NCT ID: NCT04157985

This clinical trial is studying the best length of treatment with a type of cancer therapy called PD-1/PD-L1 inhibitors, which are used for various advanced solid tumors, including lung, bladder, a...